SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001437749-11-003711
Filing Date
2011-05-31
Accepted
2011-05-31 15:53:23
Documents
1
Period of Report
2011-05-27

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT rdgdoc.html 4  
1 PRIMARY DOCUMENT rdgdoc.xml 4 4913
  Complete submission text file 0001437749-11-003711.txt   6329
Mailing Address 5980 HORTON STREET SUITE 550 EMERYVILLE CA 94608
Business Address 5980 HORTON STREET SUITE 550 EMERYVILLE CA 94608 (510) 899-8800
NovaBay Pharmaceuticals, Inc. (Issuer) CIK: 0001389545 (see all company filings)

IRS No.: 680454536 | State of Incorp.: CA | Fiscal Year End: 0120
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O NOVABAY PHARMACEUTICALS, INC. 5980 HORTON STREET, SUITE 550 EMERYVILLE CA 94608
Business Address
Khosrovi Behzad (Reporting) CIK: 0001410078 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-33678 | Film No.: 11881347